Literature DB >> 36152187

Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.

Jara Bouma1, Marjolein Soethoudt1,2, Noortje van Gils1, Lizi Xia1, Mario van der Stelt2,3, Laura H Heitman4,5.   

Abstract

Cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) are G protein-coupled receptors (GPCRs) that activate a variety of pathways upon activation by (partial) agonists including the G protein pathway and the recruitment of β-arrestins. Differences in the activation level of these pathways lead to biased signaling. Here, we describe a detailed protocol to characterize the potency and efficacy of ligands to induce or inhibit β-arrestin recruitment to the human CB1R and CB2R using the PathHunter® assay. This is a cellular assay that uses a β-galactosidase complementation system which has a chemiluminescent read-out and can be performed in 384-well plates. We have successfully used this assay to characterize a set of reference ligands (both agonists, antagonists, and an inverse agonist) on human CB1R and CB2R, of which some examples will be presented here.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biased signaling; Cannabinoid receptors; Desensitization; DiscoverX PathHunter®; Functional selectivity; GPCRs; Internalization; Receptor signaling; β-arrestin

Mesh:

Substances:

Year:  2023        PMID: 36152187     DOI: 10.1007/978-1-0716-2728-0_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

Review 1.  The endocannabinoid system and its therapeutic exploitation.

Authors:  Vincenzo Di Marzo; Maurizio Bifulco; Luciano De Petrocellis
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Signalling bias in new drug discovery: detection, quantification and therapeutic impact.

Authors:  Terry Kenakin; Arthur Christopoulos
Journal:  Nat Rev Drug Discov       Date:  2012-02-15       Impact factor: 84.694

Review 5.  Functional Selectivity at Cannabinoid Receptors.

Authors:  Richard Priestley; Michelle Glass; David Kendall
Journal:  Adv Pharmacol       Date:  2017-06-05

Review 6.  Biased signalling: from simple switches to allosteric microprocessors.

Authors:  Jeffrey S Smith; Robert J Lefkowitz; Sudarshan Rajagopal
Journal:  Nat Rev Drug Discov       Date:  2018-01-05       Impact factor: 84.694

Review 7.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

8.  Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.

Authors:  Pál Gyombolai; Eszter Boros; László Hunyady; Gábor Turu
Journal:  Mol Cell Endocrinol       Date:  2013-03-27       Impact factor: 4.102

9.  Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.

Authors:  Elise Wouters; Jolien Walraed; Michael Joseph Robertson; Max Meyrath; Martyna Szpakowska; Andy Chevigné; Georgios Skiniotis; Christophe Stove
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-04

Review 10.  Cannabinoid CB1 and CB2 Receptor Signaling and Bias.

Authors:  Mikkel Søes Ibsen; Mark Connor; Michelle Glass
Journal:  Cannabis Cannabinoid Res       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.